• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 02/20/2020
Event Type  Injury  
Manufacturer Narrative
As the device remains implanted, an investigation of the device cannot be performed.Problem due to thrombosis activation.The author stated that at follow-up the patient was discharged on aspirin.As the lot / serial no.Remains unknown, a review of the manufacturing records for the device could not be conducted.
 
Event Description
The following publication was reviewed: carotid-axillary bypass as an alternative revascularization method for zone ii thoracic endovascular aortic repair from oana bartos et al.Published in the journal of vascular surgery on february 20, 2020, (volume 72, pages 1229-36).The background of the study is to investigate the mid-term results of carotid-axillary bypass (cab) in the setting of zone ii thoracic endovascular aortic repair as an alternative method for the left subclavian artery (lsa) revascularization.The retrospective, single cohort study included overall 69 patients from march 2015 to december 2018.All patients were treated with a carotid-axillary bypass (cab) and zone ii tevar in the same session.In all cases, a 6-mm ringless gore-tex¿ vascular graft was implanted.The following adverse events was reported in the article: 04419-1: bypass thrombosis was observed in two patients.Both patients with bypass thrombosis at follow-up were discharged on aspirin; in one patient, aspirin was discontinued by the general practitioner.In both cases, patients were symptomatic with claudication of the left arm after bypass thrombosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11983486
MDR Text Key266363851
Report Number2017233-2021-02070
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K802095
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/18/2021
Initial Date FDA Received06/11/2021
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
-
-